These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 18713261

  • 1. Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation.
    Panesar M, Banerjee S, Barone GW.
    Clin Transplant; 2008; 22(6):803-8. PubMed ID: 18713261
    [Abstract] [Full Text] [Related]

  • 2. Revisiting nephrogenic systemic fibrosis in 6 kidney transplant recipients: a single-center experience.
    Lemy AA, del Marmol V, Kolivras A, High WA, Matos C, Laporte M, Nortier JL.
    J Am Acad Dermatol; 2010 Sep; 63(3):389-99. PubMed ID: 20619488
    [Abstract] [Full Text] [Related]

  • 3. Nephrogenic systemic fibrosis--a rapidly progressive disabling disease with limited therapeutic options.
    Schieren G, Wirtz N, Altmeyer P, Rump LC, Weiner SM, Kreuter A.
    J Am Acad Dermatol; 2009 Nov; 61(5):868-74. PubMed ID: 19836645
    [Abstract] [Full Text] [Related]

  • 4. Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature.
    Mathur K, Morris S, Deighan C, Green R, Douglas KW.
    J Clin Apher; 2008 Nov; 23(4):144-50. PubMed ID: 18633995
    [Abstract] [Full Text] [Related]

  • 5. UV-A1 therapy for nephrogenic systemic fibrosis.
    Tran KT, Prather HB, Cockerell CJ, Jacobe H.
    Arch Dermatol; 2009 Oct; 145(10):1170-4. PubMed ID: 19841406
    [Abstract] [Full Text] [Related]

  • 6. Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.
    Chen W, Huang SL, Huang CS, Tsai MC, Lai HM, Lui CC, Eng HL, Chang HW, Lee CH, Chuang FR.
    Eur J Dermatol; 2009 Oct; 19(1):44-9. PubMed ID: 19059824
    [Abstract] [Full Text] [Related]

  • 7. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.
    Grobner T, Prischl FC.
    Semin Dial; 2008 Oct; 21(2):135-9. PubMed ID: 18226001
    [Abstract] [Full Text] [Related]

  • 8. Large sample of nephrogenic systemic fibrosis cases from a single institution.
    Lee CU, Wood CM, Hesley GK, Leung N, Bridges MD, Lund JT, Lee PU, Pittelkow MR.
    Arch Dermatol; 2009 Oct; 145(10):1095-102. PubMed ID: 19841395
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis in 2 patients with end-stage renal disease on hemodialysis.
    Kim RH, Ma L, Hayat SQ, Ahmed MM.
    J Clin Rheumatol; 2006 Jun; 12(3):134-6. PubMed ID: 16755242
    [Abstract] [Full Text] [Related]

  • 10. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
    Wiedemeyer K, Kutzner H, Abraham JL, Thakral C, Carlson JA, Tran TA, Hausser I, Hartschuh W.
    Am J Dermatopathol; 2009 Oct; 31(7):674-81. PubMed ID: 19633532
    [Abstract] [Full Text] [Related]

  • 11. Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.
    Foss C, Smith JK, Ortiz L, Hanevold C, Davis L.
    Pediatr Dermatol; 2009 Oct; 26(5):579-82. PubMed ID: 19840315
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 13. Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium.
    Caccetta T, Chan JJ.
    Australas J Dermatol; 2008 Feb; 49(1):48-51. PubMed ID: 18186850
    [Abstract] [Full Text] [Related]

  • 14. Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling.
    Deng A, Martin DB, Spillane A, Chwalek J, St Surin-Lord S, Brooks S, Petrali J, Sina B, Gaspari A, Kao G.
    J Cutan Pathol; 2010 Feb; 37(2):204-10. PubMed ID: 19341434
    [Abstract] [Full Text] [Related]

  • 15. Nephrogenic systemic fibrosis: clinical picture and treatment.
    Marckmann P, Skov L.
    Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
    [Abstract] [Full Text] [Related]

  • 16. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin.
    Jiménez SA, Artlett CM, Sandorfi N, Derk C, Latinis K, Sawaya H, Haddad R, Shanahan JC.
    Arthritis Rheum; 2004 Aug; 50(8):2660-6. PubMed ID: 15334482
    [Abstract] [Full Text] [Related]

  • 17. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Hamilton-Persaud K, Ezell LD, Macklin JG.
    Nephrol Nurs J; 2007 Aug; 34(3):283-7; quiz 288. PubMed ID: 17644872
    [Abstract] [Full Text] [Related]

  • 18. Ten-year experience with nephrogenic systemic fibrosis: case-control analysis of risk factors.
    Bahrami S, Raman SS, Sauk S, Salehmoghaddam S, Villablanca JP, Finn JP, Lu DS.
    J Comput Assist Tomogr; 2009 Aug; 33(6):819-23. PubMed ID: 19940643
    [Abstract] [Full Text] [Related]

  • 19. [Nephrogenic fibrosing dermopathy].
    Engelen JW, Kooistra MP, Canninga-van Dijk MR, Toonstra J, Sigurdsson V.
    Ned Tijdschr Geneeskd; 2003 Dec 06; 147(49):2435-8. PubMed ID: 14694555
    [Abstract] [Full Text] [Related]

  • 20. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Othersen JB, Maize JC, Woolson RF, Budisavljevic MN.
    Nephrol Dial Transplant; 2007 Nov 06; 22(11):3179-85. PubMed ID: 17890246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.